Objectives. Ling‐Gui‐Zhu‐Gan decoction (LGZGD) is a potentially effective treatment for
heart failure, and it showed significant anti‐inflammatory potential in our previous studies …

The real-world implementation of heart failure (HF) guidelines remains unclear. Our present
systematic review and meta-analysis aimed to examine the rate of HF patients receiving …

Aims: HFA-PEFF score has been proposed for diagnosing heart failure with preserved
ejection fraction (HFpEF). Currently, there are only a limited number of tools for predicting …

Background Patients with heart failure with reduced ejection fraction (HFrEF) in Asia exhibit
many differences from those in other parts of the world. Objectives This study sought to …

Heart failure (HF) is a global pandemic affecting 64 million people worldwide. HF with
preserved ejection fraction (HFpEF) has traditionally received less attention than its main …

Methods: Data for 105,399 patients who had incident HF hospitalisations from 2007 to 2016
were identified from a national discharge database and linked to death registration records …

Aims ARIADNE aimed to assess the association between effects of sacubitril/valsartan and
no sacubitril/valsartan treatment and clinical characteristics, functional capacity, and clinical …

Heart failure with preserved ejection fraction (HFpEF) is a multi-organ systemic syndrome
that involves cardiac and extra-cardiac pathophysiological abnormalities. Its growing …

Hypertension (HT) is an important risk factor for heart failure (HF). The prevalence of HT
among the HF population is higher in Asia than in other regions around the world. In Asia …

Background. Heart failure with preserved ejection fraction (HFpEF) is a rising health problem
with heterogeneous presentation and no evidence‐based treatment. While Southeast Asia …